{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:09:39Z","timestamp":1792271379510,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>The precise grading and characterization of cervical intraepithelial neoplasia (CIN) has been the focus of pathologists for a long time. This study aimed to explore known strategies for the grading of CINs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After routine H&amp;E review, 85 lesions graded CIN 1, 2, or 3 were investigated primarily by HPV RNAscope to detect HR-HPV and LR-HPV, in combination with an HPV-DNA test and P16\/Ki67 immunohistochemistry (IHC). Then, the 85 cases were divided into a control group (49 cases) and a test group (36 cases). The former consisted of cases with consistency between morphology, HPV DNA detection and P16\/Ki67 IHC. We used them to evaluate HPV RNA distribution patterns in CINs of different grades. The latter were ambiguous cases in which pathologists could not confirm the diagnosis because of inconsistencies between morphology, HPV DNA detection and P16\/Ki67 IHC. We reassessed them by comparison to the pattern in the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression patterns of HPV mRNA signals were different in different CIN lesions. LSIL\/CIN1 lesions were mostly expressed in superficial epithelium with diffuse clustered nuclear or cytoplasmic staining; HSIL\/CIN2 were characterised by nuclear\/cytoplasmic punctate or diffuse cluster nuclear staining in the mid-surface layer, and scattered nuclear\/cytoplasmic punctate staining in basal and parabasal cells; whereas HSIL\/CIN3 showed full-thickness nucleus\/cytoplasmic scattered staining with a punctate pattern. According to the staining pattern, we corrected the diagnosis of 22 cases (22\/36, 61.1%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Because of its distinct location pattern, HPV RNAscope has obvious advantages over the HPV-DNA test, and combined with P16\/Ki67 IHC, it can help pathologists correctly grade CIN. In addition, it can effectively discriminate true CIN from normal or CIN mimic lesions, such as immature squamous metaplasia, atrophy, and inflammatory\/reactive changes. Therefore, HPV RNAscope is a valuable auxiliary diagnostic test to avoid the overtreatment and undertreatment of CIN lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-023-01308-w","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T05:03:08Z","timestamp":1676523788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["CIN grades possessing different HPV RNA location patterns and RNAscope is helpful tool for distinguishing squamous intraepithelial lesions in difficult cervical cases"],"prefix":"10.1186","volume":"18","author":[{"given":"Ruichao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"1","key":"1308_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1308_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.20892\/j.issn.2095-3941.2020.0387","volume":"17","author":"D Sun","year":"2020","unstructured":"Sun D, Li H, Cao M, He S, Lei L, Peng J, et al. Cancer burden in China: trends, risk factors and prevention. Cancer Biol Med. 2020;17(4):879\u201395.","journal-title":"Cancer Biol Med"},{"key":"1308_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13027-016-0111-8","volume":"12","author":"R Robial","year":"2017","unstructured":"Robial R, Longatto-Filho A, Roteli-Martins CM, Silveira MF, Stauffert D, Ribeiro GG, et al. Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16\/Ki-67 dual-staining. Infect Agent Cancer. 2017;12:3.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"1308_CR4","first-page":"106","volume":"52","author":"ZH He","year":"2018","unstructured":"He ZH, Kou ZQ, Xu AQ. Human papillomavirus infection and vaccination. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52(1):106\u201312.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"8","key":"1308_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","volume":"34","author":"MT Galgano","year":"2010","unstructured":"Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34(8):1077\u201387.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1308_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJMp020178","volume":"348","author":"TC Wright Jr","year":"2003","unstructured":"Wright TC Jr, Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med. 2003;348(6):489\u201390.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"1308_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00292-011-1517-0","volume":"32","author":"LC Horn","year":"2011","unstructured":"Horn LC, Klostermann K. Precancerous lesions of the uterine cervix: morphology and molecular pathology. Pathologe. 2011;32(Suppl 2):242\u201354.","journal-title":"Pathologe"},{"key":"1308_CR8","unstructured":"WHO Classification of Tumours Editorial Board ed. World Health Organization classification of tumours. In: Female genital tumours,5th edition. Lyon: IARC Press; 2020. p. 342\u20136."},{"issue":"4","key":"1308_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","volume":"26","author":"JD Carreon","year":"2007","unstructured":"Carreon JD, Sherman ME, Guill\u00e9n D, Solomon D, Herrero R, Jer\u00f3nimo J, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007;26(4):441\u20136.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"1308_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1309\/AJCPBRK7D1YIUWFP","volume":"132","author":"P Dalla Palma","year":"2009","unstructured":"Dalla Palma P, Giorgi Rossi P, Collina G, Buccoliero AM, Ghiringhello B, Gilioli E, et al. The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study. Am J Clin Pathol. 2009;132(1):125\u201332.","journal-title":"Am J Clin Pathol"},{"issue":"360","key":"1308_CR11","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"27","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, C\u00e1rdenas J, Hern\u00e1ndes, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;27(360):k499.","journal-title":"BMJ"},{"issue":"3","key":"1308_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","volume":"25","author":"DL Loopik","year":"2021","unstructured":"Loopik DL, Bentley HA, Eijgenraam MN, IntHout J, Bekkers RLM, Bentley JR. The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis. J Low Genit Tract Dis. 2021;25(3):221\u201331.","journal-title":"J Low Genit Tract Dis"},{"key":"1308_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","volume":"26","author":"M Tommasino","year":"2014","unstructured":"Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014;26:13\u201321.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"1308_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, D\u2019Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781\u20139.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1308_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/bjc.2013.296","volume":"109","author":"G Halec","year":"2013","unstructured":"Halec G, Holzinger D, Schmitt M, Flechtenmacher C, Dyckhoff G, Lloveras B, et al. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer. 2013;109(1):172\u201383.","journal-title":"Br J Cancer"},{"issue":"7","key":"1308_CR16","first-page":"3201","volume":"17","author":"K Kanthiya","year":"2016","unstructured":"Kanthiya K, Khunnarong J, Tangjitgamol S, Puripat N, Tanvanich S. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer. Asian Pac J Cancer Prev. 2016;17(7):3201\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"1308_CR17","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.7150\/jca.32743","volume":"10","author":"L Yu","year":"2019","unstructured":"Yu L, Fei L, Liu X, Pi X, Wang L, Chen S. Application of p16\/Ki-67 dual-staining cytology in cervical cancers. J Cancer. 2019;10(12):2654\u201360.","journal-title":"J Cancer"},{"issue":"11","key":"1308_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jclinpath-2018-205271","volume":"71","author":"M van Zummeren","year":"2018","unstructured":"van Zummeren M, Leeman A, Kremer WW, Bleeker MCG, Jenkins D, van de Sandt M, et al. Three-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions. J Clin Pathol. 2018;71(11):981\u20138.","journal-title":"J Clin Pathol"},{"issue":"2","key":"1308_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/modpathol.2016.168","volume":"30","author":"E Miralpeix","year":"2017","unstructured":"Miralpeix E, Genov\u00e9s J, Maria Sol\u00e9-Sede\u00f1o J, Mancebo G, Lloveras B, Bellosillo B, et al. Usefulness of p16INK4a staining for managing histological high-grade squamous intraepithelial cervical lesions. Mod Pathol. 2017;30(2):304\u201310.","journal-title":"Mod Pathol"},{"issue":"5","key":"1308_CR20","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1525-1438.2007.00899.x","volume":"17","author":"AC Guedes","year":"2007","unstructured":"Guedes AC, Brenna SM, Coelho SA, Martinez EZ, Syrj\u00e4nen KJ, Zeferino LC. p16(INK4a) Expression does not predict the outcome of cervical intraepithelial neoplasia grade 2. Int J Gynecol Cancer. 2007;17(5):1099\u2013103.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"1308_CR21","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.5858\/2007-131-1343-PAKIIA","volume":"131","author":"L Iaconis","year":"2007","unstructured":"Iaconis L, Hyjek E, Ellenson LH, Pirog EC. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection. Arch Pathol Lab Med. 2007;131(9):1343\u20139.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"1308_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1365-2559.2007.02652.x","volume":"50","author":"S Regauer","year":"2007","unstructured":"Regauer S, Reich O. CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology. 2007;50(5):629\u201335.","journal-title":"Histopathology"},{"issue":"4","key":"1308_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/PGP.0b013e31826916c7","volume":"32","author":"TM Darragh","year":"2013","unstructured":"Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, et al. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013;32(4):76\u2013115.","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"1308_CR24","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1128\/JCM.03386-12","volume":"51","author":"A Rao","year":"2013","unstructured":"Rao A, Young S, Erlich H, Boyle S, Krevolin M, Sun R, et al. Development and characterization of the cobas human papillomavirus test. J Clin Microbiol. 2013;51(5):1478\u201384.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"1308_CR25","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1128\/JCM.00883-14","volume":"52","author":"M Cui","year":"2014","unstructured":"Cui M, Chan N, Liu M, Thai K, Malaczynska J, Singh I, et al. Clinical performance of Roche Cobas 4800 HPV Test. J Clin Microbiol. 2014;52(6):2210\u20131.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1308_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12879-018-3254-y","volume":"18","author":"M Tranberg","year":"2018","unstructured":"Tranberg M, Jensen JS, Bech BH, Blaak\u00e6r J, Svanholm H, Andersen B. Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test. BMC Infect Dis. 2018;18(1):348.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1308_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ygyno.2010.09.013","volume":"120","author":"G Coquillard","year":"2011","unstructured":"Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6\/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol. 2011;120(1):89\u201393.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1308_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.5301\/tj.5000524","volume":"102","author":"D Savone","year":"2016","unstructured":"Savone D, Carrone A, Riganelli L, Merlino L, Mancino P, Benedetti PP. Management of HPV-related cervical disease: role of p16INK4a immunochemistry. Review of the literature. Tumori. 2016;102(5):450\u20138.","journal-title":"Tumori"},{"issue":"2","key":"1308_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.yexmp.2017.02.015","volume":"102","author":"G Kim","year":"2017","unstructured":"Kim G, Cho H, Lee D, Park S, Lee J, Wang HY, et al. Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer. Exp Mol Pathol. 2017;102(2):321\u20136.","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"1308_CR30","first-page":"2351","volume":"21","author":"FL Wang","year":"2017","unstructured":"Wang FL, Yang Y, Liu ZY, Qin Y, Jin T. Correlation between methylation of the p16 promoter and cervical cancer incidence. Eur Rev Med Pharmacol Sci. 2017;21(10):2351\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"1308_CR31","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1002\/cam4.2855","volume":"9","author":"A Leeman","year":"2020","unstructured":"Leeman A, Jenkins D, Del Pino M, Ordi J, Torn\u00e9 A, Doorbar J, et al. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions. Cancer Med. 2020;9(7):2454\u201361.","journal-title":"Cancer Med"},{"issue":"1","key":"1308_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13000-021-01072-9","volume":"16","author":"C Hui","year":"2021","unstructured":"Hui C, Bai H, Liu J, Lu X, Wang S, Zhang Z, et al. Accuracy of HPV E6\/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions. Diagn Pathol. 2021;16(1):13.","journal-title":"Diagn Pathol"},{"issue":"4","key":"1308_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244\u201365.","journal-title":"J Clin Pathol"},{"issue":"5","key":"1308_CR34","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1128\/jvi.68.5.2811-2821.1994","volume":"68","author":"DM von Knebel","year":"1994","unstructured":"von Knebel DM, Rittm\u00fcller C, Aengeneyndt F, Jansen-D\u00fcrr P, Spitkovsky D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6\u2013p53 and E7-pRB interactions. J Virol. 1994;68(5):2811\u201321.","journal-title":"J Virol"},{"issue":"7","key":"1308_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/cas.13264","volume":"108","author":"Y Yoshimatsu","year":"2017","unstructured":"Yoshimatsu Y, Nakahara T, Tanaka K, Inagawa Y, Narisawa-Saito M, Yugawa T, et al. Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes. Cancer Sci. 2017;108(7):1303\u20139.","journal-title":"Cancer Sci"},{"key":"1308_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4939-7565-5_15","volume":"1726","author":"M Pandey","year":"2018","unstructured":"Pandey M, Bhosale PG, Mahimkar MB. Detection of HPV E6\/E7 mRNA in Clinical Samples Using RNA In Situ Hybridization. Methods Mol Biol. 2018;1726:167\u201375.","journal-title":"Methods Mol Biol"},{"issue":"9590","key":"1308_CR37","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907.","journal-title":"Lancet"},{"issue":"2","key":"1308_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.1866","volume":"208","author":"PJ Snijders","year":"2006","unstructured":"Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006;208(2):152\u201364.","journal-title":"J Pathol"},{"issue":"4","key":"1308_CR39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gyobfe.2008.02.008","volume":"36","author":"F Denis","year":"2008","unstructured":"Denis F, Hanz S, Alain S. Clearance, persistence and recurrence of HPV infection. Gynecol Obstet Fertil. 2008;36(4):430\u201340.","journal-title":"Gynecol Obstet Fertil"},{"issue":"4","key":"1308_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/10408363.2012.707174","volume":"49","author":"PK Chan","year":"2012","unstructured":"Chan PK, Picconi MA, Cheung TH, Giovannelli L, Park JS. Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci. 2012;49(4):117\u201336.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"11","key":"1308_CR41","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/1471-0528.15893","volume":"126","author":"A Del Mistro","year":"2019","unstructured":"Del Mistro A, Giorgi Rossi P, Frayle H, Pasquale L, Campari C, Ronco G, et al. Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study. BJOG. 2019;126(11):1365\u201371.","journal-title":"BJOG"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T05:09:22Z","timestamp":1676524162000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01308-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1962791\/v1","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols follow the ethical guidelines of the Helsinki Declaration and were approved by the ethics committee of Third Affiliated Hospital of Guangzhou Medical University. All authors approved the final manuscript to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}